The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine has received renewal of its designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI).
The designation recognizes Siteman’s clinical research, basic science, community outreach and education activities. The renewal includes $23 million in research funding for the next five years.
“NCI designation as a Comprehensive Cancer Center confers the highest recognition of our exceptional cancer-focused scientists, clinicians and staff throughout Washington University and Barnes-Jewish Hospital,” says Timothy J. Eberlein, MD, director of the Siteman Cancer Center. “Most importantly, we are translating our cutting-edge science into better treatments for the more than 40,000 cancer patients we see each year.”
To achieve comprehensive status, a cancer center must succeed in a rigorous, multi-stage review process, which included a 1,700-page grant proposal followed by a site visit by a panel of national experts in January.
NCI is a part of the U.S. Department of Health and Human Services and the National Institutes of Health.
READ MORE
No comments:
Post a Comment